Magnevist Side Effects
Please note - some side effects for Magnevist may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects of Magnevist - for the Consumer
Magnevist
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Magnevist:
Seek medical attention right away if any of these SEVERE side effects occur when using Magnevist:Dizziness; headache; minor pain, swelling, coldness, or redness at the injection site; nausea; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); changes in vision; fainting; fast or irregular heartbeat; fever or chills; joint stiffness; muscle weakness; numbness in an arm or leg; red or dark patches, pain, burning, or swelling of the skin; scaling, hardening, or tightening of the skin; seizures; severe stomach pain; sharp or crushing chest pain; skin lesions; sudden leg pain; sudden, severe headache; sudden shortness of breath; tiredness or weakness.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
TopMagnevist Side Effects - for the Professional
Magnevist
Clinical Trial Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The mean age of the 1272 patients who received Magnevist Injection in pre-market clinical trials was 46.4 years (range 2 to 93 years). Of these patients, 55% (700) were male and 45% (572) were female. Of the 1271 patients who received Magnevist Injection and for whom race was reported, 82.1% (1043) were Caucasian, 9.7% (123) were Black, 5.3% (67) were Hispanic, 2.1% (27) were Oriental/Asian, and 0.9% (11) were other.
The most common adverse reaction was headache (4.8%). The majority of headaches were transient and of mild to moderate severity. Other adverse reactions that occurred in ≥ 1% of patients included: nausea (2.7%), injection site coldness/localized coldness (2.3%) and dizziness (1%).
The following additional adverse reactions occurred in less than 1% of the patients:
General Disorders: Injection site symptoms, namely, pain, localized warmth, and burning sensation; substernal chest pain, back pain, pyrexia, asthenia, feeling cold, generalized warmth, localized edema, fatigue, and chest tightness, and anaphylactoid reactions characterized by cardiovascular, respiratory and/or cutaneous symptoms.
Cardiovascular: Hypotension, hypertension, tachycardia, migraine, syncope, vasodilatation, pallor, angina pectoris, phlebitis.
Digestive: Abdominal discomfort, teeth pain, increased salivation, abdominal pain, vomiting, constipation, diarrhea.
Nervous System: Agitation, anxiety, thirst, anorexia, nystagmus, somnolence, diplopia, loss of consciousness, convulsions (including grand mal), paresthesia.
Respiratory System: Throat irritation, rhinitis, sneezing, dyspnea, bronchospasm, cough.
Skin: Rash, sweating (hyperhidrosis), pruritus, urticaria (hives), facial edema, epidermal necrolysis.
Special Senses: Tinnitus, conjunctivitis, visual field defect, taste abnormality, dry mouth, lacrimation, eye irritation, eye pain, ear pain.
Postmarketing Experience
The following additional adverse reactions have been identified during postmarketing use of Magnevist. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
The most serious reactions were nephrogenic systemic fibrosis and acute reactions including cardiac or respiratory arrest, anaphylactic shock, shock, respiratory distress, and laryngeal edema. The most frequently reported adverse reactions in the postmarketing experience were nausea, vomiting, urticaria and rash.
General Disorders and Administration Site Conditions: Nephrogenic systemic fibrosis, body temperature decreased, tremor, shivering (chills), regional lymphangitis (lymphangitis), pelvic pain.
Hypersensitivity Reactions: Fatal cardiac or respiratory arrest, respiratory distress, cyanosis, laryngeal edema, laryngospasm, pharyngeal edema, angioedema, and anaphylactoid reactions characterized by cardiovascular, respiratory and/or cutaneous symptoms, rarely resulting in death..
Cardiac Disorders: Cardiac arrest, heart rate decreased, arrhythmia, non-specific ECG changes, death related to myocardial infarction or other undetermined causes.
Renal and Urinary Disorders: Acute renal failure, increased serum creatinine in patients with renal insufficiency urinary incontinence, urinary urgency.
Ear and Labyrinth Disorders: Hearing impaired.
Eye Disorders: Visual disturbance.
Musculoskeletal and Connective Tissue Disorder: Arthralgia.
Nervous System Disorders: Coma, parosmia, speech disorder.
Respiratory System: Respiratory arrest, pulmonary edema.
Vascular Disorders: Thrombophlebitis, deep vein thrombophlebitis, compartment syndrome requiring surgical intervention.
Skin Disorders: Erythema multiforme, pustules (rash pustular).
OVERDOSAGE
Systemic consequences associated with overdosage of Magnevist Injection have not been reported.
TopSide Effects by Body System - for Healthcare Professionals
Cardiovascular
Cardiovascular side effects have included hypotension, hypertension, arrhythmia, tachycardia, syncope, vasodilation, pallor, nonspecific ECG changes, angina pectoris, death related to myocardial infarction, phlebitis, thrombophlebitis, deep venous thrombophlebitis, and compartment syndrome requiring surgery.
Gastrointestinal
Gastrointestinal side effects have included gastrointestinal distress, stomach pain, increased salivation, abdominal pain, vomiting, constipation, thirst, anorexia, dry mouth, and diarrhea.
Nervous system
Nervous system side effects have included agitation, anxiety, migraine, nystagmus, drowsiness, stupor, paresthesia, and convulsions.
Ocular
Ocular side effects have included diplopia, conjunctivitis, visual field defect, lacrimation disorder, eye irritation, and eye pain.
Respiratory
Respiratory side effects have included throat irritation, rhinorrhea, sneezing, dyspnea, wheezing, laryngismus, cough, and respiratory complaints.
Dermatologic
Dermatologic side effects have included rash, sweating, pruritus, urticaria, facial edema, erythema multiforme, epidural necrolysis, and pustules.
Local
Local side effects have included pain, localized warmth, and burning sensation at the injection site.
Hypersensitivity
Hypersensitivity side effects have included substernal chest pain, back pain, fever, weakness, generalized coldness, generalized warmth, localized edema, tiredness, chest tightness, trembling, shivering, tension in the extremities, regional lymphangitis, pelvis pain, and anaphylactoid reactions.
Other
Other side effects have included tinnitus and taste abnormalities.
TopMore Magnevist resources
- Magnevist Prescribing Information (FDA)
- Magnevist Advanced Consumer (Micromedex) - Includes Dosage Information
- Magnevist MedFacts Consumer Leaflet (Wolters Kluwer)
- Magnevist Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
